Developing nose-to-brain delivery of AAV2-mediated gene-therapy for neurodegenerative diseases
Cite
Citation style:
Could not load citation form.
Access Statistic

Rights
Use and reproduction:
All rights reserved

Use and reproduction:
All rights reserved